Health-related quality of life effects of enzalutamide in patients with metastatic castration-resistant prostate cancer: an in-depth post hoc analysis of EQ-5D data from the PREVAIL trial User HealthEconBot, in the Health Economics Journal Articles subreddit, 24 Jun 2017